Lisata amends charter for Nov. 2026 15-for-1 reverse stock split
Lisata Therapeutics amended its charter to implement a 15-for-1 reverse stock split effective November 23, 2026, affecting shares, treasury stock, and options. Market relevance: This corporate action signals the company expects that its stock price will increase following the split, though the price per share will drop proportionally.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed